| 1 |
28088282 | Conjugation site analysis of antibody-drug-conjugates (ADCs) by signature ion fingerprinting and normalized area quantitation approach using nano-liquid chromatography coupled to high resolution mass spectrometry. | 2017 Feb 22 |
7 |
| 2 |
28131055 | LC-MS/MS method for the simultaneous determination of Lys-MCC-DM1, MCC-DM1 and DM1 as potential intracellular catabolites of the antibody-drug conjugate trastuzumab emtansine (T-DM1). | 2017 Apr 15 |
1 |
| 3 |
28388007 | Aberrant intracellular metabolism of T-DM1 confers T-DM1 resistance in human epidermal growth factor receptor 2-positive gastric cancer cells. | 2017 Jul |
2 |
| 4 |
25694334 | Native mass spectrometry and ion mobility characterization of trastuzumab emtansine, a lysine-linked antibody drug conjugate. | 2015 Aug |
1 |
| 5 |
21391620 | Design of antibody-maytansinoid conjugates allows for efficient detoxification via liver metabolism. | 2011 Apr 20 |
1 |
| 6 |
20698491 | Physicochemical stability of the antibody-drug conjugate Trastuzumab-DM1: changes due to modification and conjugation processes. | 2010 Sep 15 |
3 |